Due to the observed overlap between CD133-M and the PN subtype and CD44-M and CD15-M with the MES subtype, we investigated the utility of a dichotomous CD133-M/CD44-M classification to predict survival. The gene discussed is CD44; the disease is poikiloderma with neutropenia.